AZENTA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.18 USD | +1.32% |
|
+3.02% | -19.90% |
Chart calendar Azenta, Inc.
1c644fee3206d26f8d3244177e6d.O8T3_lMhQz8ByFqKtj7M1_ICrgZawEClMRY5kmGo-kE.dai4zhdLGWcyjgLMhUeuvYsw7Gw9gnfIUH8B5FjFvhtu6cPKalQRbVSiFw~48bb7a3f5c58bf84eb913fb49121e460
Upcoming events on Azenta, Inc.
Past events on Azenta, Inc.
| 08/04/2024 17:45 | Needham Healthcare Conference |
| 19/03/2024 16:45 | KeyBanc Life Sciences & MedTech Forum |
| 14/03/2024 13:00 | Investor Day |
| 07/02/2024 21:30 | Q1 2024 Earnings Call |
| 07/02/2024 21:05 | Q1 2024 Earnings Release |
| 05/02/2024 17:00 | Society for Laboratory Automation and Screening International Conference |
| 30/01/2024 15:00 | Annual General Meeting |
| 18/01/2024 15:15 | Needham Growth Conference |
| 11/01/2024 15:30 | JPMorgan Healthcare Conference |
| 28/11/2023 | Evercore ISI HealthCONx Conference |
| 16/11/2023 17:00 | Stephens Investment Conference |
| 13/11/2023 21:30 | Q4 2023 Earnings Call |
| 13/11/2023 21:07 | Q4 2023 Earnings Release |
| 13/09/2023 19:55 | Morgan Stanley Global Healthcare Conference |
| 12/09/2023 14:05 | Baird Global Healthcare Conference |
| 15/08/2023 23:00 | UBS MedTech, Tools and Genomics Summit |
| 13/08/2023 | Needham Virtual MedTech & Diagnostics Conference |
| 08/08/2023 21:30 | Q3 2023 Earnings Call |
| 08/08/2023 21:05 | Q3 2023 Earnings Release |
| 08/06/2023 16:30 | Jefferies Global Healthcare Conference |
Past dividends on Azenta, Inc.
| 01/12/2021 | Quarterly 0.1 USD |
| 01/09/2021 | Quarterly 0.1 USD |
| 02/06/2021 | Quarterly 0.1 USD |
| 03/03/2021 | Quarterly 0.1 USD |
| 02/12/2020 | Quarterly 0.1 USD |
| 02/09/2020 | Quarterly 0.1 USD |
| 03/06/2020 | Quarterly 0.1 USD |
| 04/03/2020 | Quarterly 0.1 USD |
| 04/12/2019 | Quarterly 0.1 USD |
| 04/09/2019 | Quarterly 0.1 USD |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 782 777 0.63% | 897 885 1.37% | 1 194 1 188 0.48% | 555 552 0.69% | 665 656 1.44% | 704 |
|
EBITDA Million USD | Released Forecast Spread | 128 139 -7.76% | 161 153 5.54% | 246 298 -17.53% | 62,5 64,3 -2.77% | 30,4 26,8 13.32% | 50,0 |
|
EBIT Million USD | Released Forecast Spread | 90,7 92,1 -1.53% | 122 113 8.57% | 180 240 -24.9% | 28,5 25,8 10.28% | -15,3 -22,3 31.52% | -5,82 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9,94 12,7 -21.73% | 75,0 64,7 15.88% | -49,0 157 -131.15% | -9,94 -12,7 21.82% | -30,4 -37,0 17.69% | -33,9 |
|
Net income Million USD | Released Forecast Spread | 438 29,3 1395.74% | 64,9 53,4 21.52% | 111 125 -11.33% | 2 133 2 149 -0.76% | -14,3 -27,4 47.93% | -27,5 |
|
EPS USD | Released Forecast Spread | 6,05 0,47 1178.18% | 0,88 0,73 21.1% | 1,49 1,71 -12.87% | 28,5 7,03 304.98% | -0,22 -0,40 44.72% | -0,62 |
| Announcement Date | 06/11/19 | 10/11/20 | 10/11/21 | 14/11/22 | 13/11/23 | - |
Quarterly results
| Fiscal Period | Septiembre | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 140 135 3.12% | 146 142 2.42% | 133 133 0.03% | 138 134 2.87% | 178 181 -1.65% | 148 162 -8.34% | 166 153 8.23% | 172 164 5.16% | 154 151 2.09% | 160 | 188 | 202 | 183 | 170 |
|
EBITDA Million USD | Released Forecast Spread | 19,8 17,9 10.73% | 19,4 21,4 -9.52% | 13,8 13,1 5.52% | 9,45 8,30 13.87% | 12,0 14,2 -15.9% | -2,40 1,02 -334.91% | 12,9 0,30 4235.07% | 7,94 4,16 91.01% | 4,56 0,40 1047.36% | 7,26 | 16,9 | 21,6 | 20,0 | 16,4 |
|
EBIT Million USD | Released Forecast Spread | 12,2 10,7 14.04% | 9,70 11,1 -12.6% | 4,46 6,63 -32.66% | 2,07 0,00 - | -0,04 4,97 -100.81% | -13,3 -11,4 -16.42% | -1,06 -12,7 91.67% | -0,90 -7,95 88.73% | -8,71 -12,9 32.43% | -6,90 | 2,85 | 7,57 | 6,16 | 2,55 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,82 -14,0 86.99% | -4,99 0,36 -1488.42% | 0,28 -4,83 105.75% | -3,40 -6,13 44.54% | -15,9 -9,30 -70.7% | -5,25 -18,7 71.98% | -3,67 -21,1 82.64% | -5,64 -12,2 53.7% | -15,9 -14,3 -11.13% | -11,3 | -5,78 | -0,69 | -3,24 | -8,60 |
|
Net income Million USD | Released Forecast Spread | 43,3 -11,2 486.79% | 2 116 4,77 44251.61% | -9,57 -9,05 -5.79% | -20,8 -5,20 -299.63% | -11,2 -7,89 -42.34% | -4,93 -14,7 66.54% | -1,47 -12,3 88.04% | 3,38 -10,2 133.05% | -15,7 -11,4 -38.18% | -7,80 | -5,33 | -1,02 | -4,54 | -8,42 |
|
EPS USD | Released Forecast Spread | 0,58 -0,11 627.27% | 28,2 0,05 53519.05% | -0,13 -0,08 -62.5% | -0,28 -0,07 -286.21% | -0,15 -0,12 -30.43% | -0,07 -0,22 67.44% | -0,02 -0,15 86.3% | 0,06 -0,17 135.71% | -0,28 -0,21 -35.92% | -0,18 | -0,11 | -0,02 | -0,09 | -0,17 |
| Announcement Date | 08/02/22 | 09/05/22 | 09/08/22 | 14/11/22 | 08/02/23 | 09/05/23 | 08/08/23 | 13/11/23 | 07/02/24 | - | - | - | - | - |
More events
Past sector events for Azenta, Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AZTA Stock
- Calendar Azenta, Inc.
